| Reddy S, Kane C, Pitrosky B, et al.
Clinical utility of desvenlafaxine 50 mg/d for treating MDD: a review of two randomized placebo-controlled trials for the practicing physician. [JOURNAL ARTICLE]
Curr Med Res Opin 2009 Nov 17.
Abstract | Full Citation | | Soares CN, Kornstein SG, Thase ME, et al.
Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials. [Journal Article, Research Support, Non-U.S. Gov't]
J Clin Psychiatry 2009 Oct; 70(10):1365-71.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Lilue M, Palacios S
[Non-hormonal treatment for vasomotor symptoms during menopause: role of desvenlafaxine] [English Abstract, Journal Article]
Ginecol Obstet Mex 2009 Oct; 77(10):475-81.
Abstract | Full Citation | | Desvenlafaxine: application withdrawal. Desvenlafaxine: withdrawal of marketing application for depression also. [Journal Article]
Prescrire Int 2009 Oct; 18(103):197.
Abstract | Full Citation | | Carroll DG, Kelley KW
Use of Antidepressants for Management of Hot Flashes. [JOURNAL ARTICLE]
Pharmacotherapy 2009 Nov; 29(11):1357-1374.
Abstract | Full Citation | Find Related Articles | | Montgomery SA, Fava M, Padmanabhan SK, et al.
Discontinuation symptoms and taper/poststudy-emergent adverse events with desvenlafaxine treatment for major depressive disorder. [JOURNAL ARTICLE]
Int Clin Psychopharmacol 2009 Sep 23.
Abstract | Full Citation | | Lewis V
Undertreatment of menopausal symptoms and novel options for comprehensive management. [JOURNAL ARTICLE]
Curr Med Res Opin 2009 Sep 23.
Abstract | Full Citation | Find Related Articles | | Kornstein SG, Fava M, Jiang Q, et al.
Analysis of depressive symptoms in patients with major depressive disorder treated with desvenlafaxine or placebo. [Journal Article]
Psychopharmacol Bull 2009; 42(3):21-35.
Abstract | Full Citation | Find Related Articles | | Cascade E, Kalali AH, Halbreich U
Antidepressant prescribing by specialty and treatment of premenstrual dysphoric disorder. [Journal Article]
Psychiatry (Edgmont) 2008 Dec; 5(12):14-5.
Abstract | Full Citation | Find Related Articles | | Tourian KA, Padmanabhan SK, Groark J, et al.
Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: An 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies. [Journal Article]
Clin Ther 2009 Jun; 31(6 Pt 2):1405-23.
Abstract | Full Citation |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
